{"id":"W2951482915","doi":"10.1002/hon.99_2630","title":"EXPLORATORY BIOMARKER ANALYSIS IN THE PH 3 ECHELON‐1 STUDY: WORSE OUTCOME WITH ABVD IN PATIENTS WITH ELEVATED BASELINE LEVELS OF SCD30 AND TARC","year":2019,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Brentuximab vedotin; Internal medicine; Dacarbazine; Oncology; ABVD; Biomarker; Post-hoc analysis; Progression-free survival; Gastroenterology; Lymphoma; Overall survival; CD30; Vincristine; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009514255,0.0004139849,0.00064828,0.000259093,0.0002071899,0.000511999,0.0003156794,0.0003775546,0.001195468],"category_scores_gemma":[0.0006797046,0.0001489994,0.0007013054,0.0003049349,0.0002177796,0.0003278046,0.0003935011,0.0005126963,0.000160099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002144229,"about_ca_system_score_gemma":0.0002743382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004385817,"about_ca_topic_score_gemma":0.0005435955,"domain_scores_codex":[0.9997364,0.00010616,0.00001670588,0.00007081427,0.00003244801,0.00003749611],"domain_scores_gemma":[0.9995679,0.0001015888,0.0001212414,0.00004743739,0.00003234955,0.0001295508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03691395,0.0004857583,0.9505556,0.00006240771,0.0007784247,0.0002410431,0.00006536325,0.0004498488,0.00389137,0.00004900503,0.0003348376,0.006172307],"study_design_scores_gemma":[0.002074625,0.008588075,0.9852229,0.00001497261,0.0005181137,0.000594368,0.00007278883,0.001164756,0.0009645414,0.0001429857,0.0006303576,0.00001141394],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999177,0.0002275701,0.0000864652,0.00001814763,0.000004227923,0.00003428708,0.0002541618,0.000003341157,0.0001947791],"genre_scores_gemma":[0.9991624,0.00003911112,0.00009033448,0.00002935417,0.00001353223,0.0000280726,0.0005018955,0.000001357609,0.0001338696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001195468,"threshold_uncertainty_score":0.005031645,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04577763203083163,"score_gpt":0.3204171451610274,"score_spread":0.2746395131301957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}